News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
187 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17865)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (258)
2 (248)
3 (119)
4 (1)
5 (30)
6 (211)
7 (196)
8 (187)
9 (224)
10 (123)
11 (42)
12 (30)
13 (282)
14 (254)
15 (234)
16 (227)
17 (162)
18 (1)
19 (7)
20 (203)
21 (157)
22 (183)
23 (103)
24 (13)
25 (1)
27 (71)
28 (66)
29 (85)
30 (85)
31 (20)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
31
Genetown
Bruker Announces $500 Million Private Placement of Senior Notes to Support Strategic Growth Objectives
Bruker Corporation (Nasdaq: BRKR) announced today that it has completed a new private placement of 10-year senior notes in the aggregate principal amount of $500 million to enhance its financial flexibility and fund strategic growth objectives.
December 8, 2021
·
3 min read
Biotech Bay
Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital
Avistone Pharmaceuticals today announced it has received a strategic investment of more than $200 million led by Vivo Capital with participation from Bain Capital and Primavera Capital (collectively the “Investor Group”).
December 8, 2021
·
7 min read
Biotech Beach
GT Biopharma Demonstrates Novel B7-H3 Targeting Dual Camelid Nanobody BiKE and GTB-5550 Induce NK Cell Activation Against Broad Spectrum of Tumors at ESMO IO Congress 2021
GT Biopharma, Inc. today announced that the Company’s mini-poster presentation abstract is now broadly available on the European Society for Medical Oncology (“ESMO”) Immuno-Oncology (“IO”) Congress 2021 abstracts webpage.
December 8, 2021
·
9 min read
BioCapital
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Financing and Board appointments provide foundation for KeifeRx to accelerate development of its pipeline of optimized tyrosine kinase inhibitors targeting neurodegenerative diseases.
December 8, 2021
·
6 min read
Business
Medable and Vault Health Partner to Expand Direct-to-Patient Testing and eCare for Decentralized Clinical Trials
Medable and Vault Health Partner to Expand Direct-to-Patient Testing and eCare for Decentralized Clinical Trials.
December 8, 2021
·
4 min read
Lexaria’s DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2
Lexaria Bioscience Corp. is pleased to issue follow-up results from human clinical study HYPER-H21-2 confirming that DehydraTECH TM -processed cannabidiol reduces arterial stiffness, potentially broadening its application to treatment of cardiovascular and other disease states beyond hypertension where it has already shown tremendous promise.
December 8, 2021
·
8 min read
Deals
Reata Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Discuss Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome
Reata Pharmaceuticals, Inc announced today that Nasdaq has halted trading of the Company’s common stock.
December 8, 2021
·
3 min read
Genetown
Cytovia Therapeutics’ Scientific Leadership to Present at Upcoming Conferences
Cytovia Therapeutics, Inc. announced today that its scientific leadership will present at the following upcoming conferences: iPSC-Derived Cell Therapies Summit (Virtual Event).
December 8, 2021
·
3 min read
BioMidwest
Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication
Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.”
December 8, 2021
·
4 min read
Drug Development
Veru Announces Presentation of Preclinical Evidence Supporting the Therapeutic Benefit of Enobosarm Alone or in Synergistic Combination with a CDK4/6 Inhibitor Against Palbociclib Resistant Metastatic Breast Cancer
Veru Inc. today announced that human preclinical data will be presented at the San Antonio Breast Cancer Symposium being held December 07-10, 2021, in San Antonio, TX.
December 8, 2021
·
10 min read
Previous
13 of 19
Next